Kenya joins Ghana and Malawi in rolling out the vaccine to more children at risk
Malaria parasite life cycleMany factors make malaria vaccine development challenging.
R&D and IntroductionMVI's strategy supports the near-term goal of controlling malaria in the populations most at risk, as well as the long-term goal of complete eradication of the disease.
RTS,S/AS01The first vaccine recommended for use by the World Health Organization to prevent malaria in children.
Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
17 Mar 2023
PATH welcomes US$ 5 million grant to expand malaria vaccine access in Ghana, Kenya, and Malawi
19 Apr 2022
PATH welcomes commitment by Gavi board to finance wider rollout of the world’s first malaria vaccine, RTS,S
2 Dec 2021
PATH welcomes remarkable results from clinical trial combining RTS,S/AS01 malaria vaccine with Seasonal Malaria Chemoprevention
25 Aug 2021
GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine
27 Jan 2021